跳至主要内容
临床试验/NCT00905658
NCT00905658Unknown2 期

Systematic Nutritional Care in Patients Receiving First-line Chemotherapy for Metastatic Gynecologic Cancer in a Phase II Study

Centre Oscar Lambret2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2008年6月最近更新:
适应症

试验速览

阶段
2 期
入组人数
120
试验地点
2
主要终点
Quality of life (QLQ-C30)

研究概览

简要总结

RATIONALE: Learning about the effect of nutritional supplements on quality of life in patients receiving chemotherapy for cancer may help doctors plan the best treatment.

PURPOSE: This randomized phase II trial is studying nutritional supplements to see how well they work in improving quality of life during first-line chemotherapy in patients with metastatic gynecologic cancer.

详细描述

OBJECTIVES:

Primary

  • Measure quality of life (QLQ-C30) at week 18 in patients with metastatic gynecological cancer receiving systematic nutritional supplements during first-line chemotherapy.

Secondary

  • Study the maintenance or improvement of intake and nutritional status.
  • Study the quality of life during chemotherapy.
  • Evaluate tolerance and compliance to treatment with nutritional supplements.
  • Evaluate the feasibility of and the tolerance to chemotherapy.
  • Measure the overall survival over 18 weeks.
  • Analyze the cost-effectiveness of different strategies of nutritional care.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Supportive Care

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Quality of life (QLQ-C30)

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验